$IMUC
EOM Pharmaceutical Holdings, Inc.

2013 Q2 Form 10-Q Financial Statement

#000156459013000239 Filed on August 08, 2013

View on sec.gov

Income Statement

Concept 2013 Q2 2012 Q2
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $970.0K $940.0K
YoY Change 3.19% -3.09%
% of Gross Profit
Research & Development $1.210M $2.190M
YoY Change -44.74% 154.61%
% of Gross Profit
Depreciation & Amortization $10.84K $11.44K
YoY Change -5.26% 14.44%
% of Gross Profit
Operating Expenses $2.180M $2.190M
YoY Change -0.44% 19.65%
Operating Profit -$2.182M -$3.131M
YoY Change -30.3%
Interest Expense $2.030M -$3.320M
YoY Change -161.14% -1285.71%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$150.3K -$6.452M
YoY Change -97.67% 316.25%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$150.3K -$6.452M
YoY Change -97.67% 316.25%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 -$0.16
Diluted Earnings Per Share $0.00 -$0.16
COMMON SHARES
Basic Shares Outstanding 52.73M
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q2 2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $25.45M $11.34M
YoY Change 124.43% 11.72%
Cash & Equivalents $25.45M $11.34M
Short-Term Investments
Other Short-Term Assets $400.0K $620.0K
YoY Change -35.48% 1450.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $25.85M $11.96M
YoY Change 116.14% 17.37%
LONG-TERM ASSETS
Property, Plant & Equipment $90.00K $100.0K
YoY Change -10.0% 150.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $241.6K $10.00K
YoY Change 2315.75% 0.0%
Total Long-Term Assets $330.0K $100.0K
YoY Change 230.0% 100.0%
TOTAL ASSETS
Total Short-Term Assets $25.85M $11.96M
Total Long-Term Assets $330.0K $100.0K
Total Assets $26.18M $12.06M
YoY Change 117.08% 17.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $330.0K $570.0K
YoY Change -42.11% 850.0%
Accrued Expenses $490.0K $450.0K
YoY Change 8.89% -8.16%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $820.0K $1.020M
YoY Change -19.61% 85.45%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.310M $8.700M
YoY Change -73.45% 49.23%
Total Long-Term Liabilities $2.310M $8.700M
YoY Change -73.45% 49.23%
TOTAL LIABILITIES
Total Short-Term Liabilities $820.0K $1.020M
Total Long-Term Liabilities $2.310M $8.700M
Total Liabilities $3.130M $9.720M
YoY Change -67.8% 52.35%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $23.05M $2.340M
YoY Change
Total Liabilities & Shareholders Equity $26.18M $12.06M
YoY Change 117.08% 17.77%

Cashflow Statement

Concept 2013 Q2 2012 Q2
OPERATING ACTIVITIES
Net Income -$150.3K -$6.452M
YoY Change -97.67% 316.25%
Depreciation, Depletion And Amortization $10.84K $11.44K
YoY Change -5.26% 14.44%
Cash From Operating Activities -$1.910M -$3.310M
YoY Change -42.3% 160.63%
INVESTING ACTIVITIES
Capital Expenditures -$30.00K $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities -$30.00K $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.300M 1.090M
YoY Change 202.75% 541.18%
NET CHANGE
Cash From Operating Activities -1.910M -3.310M
Cash From Investing Activities -30.00K 0.000
Cash From Financing Activities 3.300M 1.090M
Net Change In Cash 1.360M -2.220M
YoY Change -161.26% 101.82%
FREE CASH FLOW
Cash From Operating Activities -$1.910M -$3.310M
Capital Expenditures -$30.00K $0.00
Free Cash Flow -$1.880M -$3.310M
YoY Change -43.2% 160.63%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Revenues
Revenues
0
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
11736
CY2012Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
103617
CY2013Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
241575
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9060086
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-604171
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-150329
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-6451817
us-gaap Net Income Loss
NetIncomeLoss
-5124120
us-gaap Net Income Loss
NetIncomeLoss
-14341252
us-gaap Net Income Loss
NetIncomeLoss
-46200450
CY2013Q2 us-gaap Other Preferred Stock Dividends And Adjustments
OtherPreferredStockDividendsAndAdjustments
0
CY2012Q2 us-gaap Other Preferred Stock Dividends And Adjustments
OtherPreferredStockDividendsAndAdjustments
0
CY2012Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6451817
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5124120
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-48292950
CY2005 us-gaap Net Income Loss
NetIncomeLoss
-246004
CY2006 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3522
CY2005 imuc Common Stock Issued For Research And Development Per Share
CommonStockIssuedForResearchAndDevelopmentPerShare
0.99
CY2006 imuc Common Stock Issued For Research And Development Per Share
CommonStockIssuedForResearchAndDevelopmentPerShare
1.00
CY2006 imuc Common Stock Issued For Cash In Private Placements Per Share
CommonStockIssuedForCashInPrivatePlacementsPerShare
1.00
CY2007 imuc Common Stock Issued For Cash In Private Placements Per Share
CommonStockIssuedForCashInPrivatePlacementsPerShare
1.50
CY2007Q4 us-gaap Stockholders Equity
StockholdersEquity
4997709
us-gaap Revenues
Revenues
300000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20888944
CY2013Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
179946
CY2012Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2189633
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2628831
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4188169
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1557687
CY2012Q2 us-gaap Costs And Expenses
CostsAndExpenses
3130572
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
344074
CY2012Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
837322
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
348724
CY2013Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
788420
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1643120
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14242433
CY2013Q2 us-gaap Costs And Expenses
CostsAndExpenses
2181936
us-gaap Costs And Expenses
CostsAndExpenses
4530592
us-gaap Costs And Expenses
CostsAndExpenses
6180013
us-gaap Costs And Expenses
CostsAndExpenses
44191463
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2181936
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3130572
us-gaap Operating Income Loss
OperatingIncomeLoss
-4530592
us-gaap Operating Income Loss
OperatingIncomeLoss
-6180013
us-gaap Operating Income Loss
OperatingIncomeLoss
-43891463
CY2013Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
4094
CY2012Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1975
us-gaap Investment Income Interest
InvestmentIncomeInterest
10643
us-gaap Investment Income Interest
InvestmentIncomeInterest
3009
us-gaap Investment Income Interest
InvestmentIncomeInterest
358385
CY2013Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0
CY2012Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
368524
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
397294
CY2013Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
2027513
CY2012Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-3323220
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-7795724
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-2270078
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-150329
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-6451817
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-5124120
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-14341252
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-46200450
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Other Preferred Stock Dividends And Adjustments
OtherPreferredStockDividendsAndAdjustments
0
us-gaap Other Preferred Stock Dividends And Adjustments
OtherPreferredStockDividendsAndAdjustments
0
us-gaap Other Preferred Stock Dividends And Adjustments
OtherPreferredStockDividendsAndAdjustments
2092500
CY2013Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-150329
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
3232060
CY2012Q2 imuc Earning Before Dividend Adjustment Per Share Basic And Diluted
EarningBeforeDividendAdjustmentPerShareBasicAndDiluted
-0.16
imuc Earning Before Dividend Adjustment Per Share Basic And Diluted
EarningBeforeDividendAdjustmentPerShareBasicAndDiluted
-0.10
imuc Earning Before Dividend Adjustment Per Share Basic And Diluted
EarningBeforeDividendAdjustmentPerShareBasicAndDiluted
-0.37
imuc Earning Before Dividend Adjustment Per Share Basic And Diluted
EarningBeforeDividendAdjustmentPerShareBasicAndDiluted
-2.61
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-14341252
CY2013Q2 imuc Earning Before Dividend Adjustment Per Share Basic And Diluted
EarningBeforeDividendAdjustmentPerShareBasicAndDiluted
0.00
CY2013Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
52972702
CY2012Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
39892802
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
52264104
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
38497810
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
18472012
CY2004Q1 us-gaap Stockholders Equity
StockholdersEquity
97
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
150
us-gaap Net Income Loss
NetIncomeLoss
-11741
CY2004Q4 us-gaap Stockholders Equity
StockholdersEquity
-11494
CY2005Q4 us-gaap Stockholders Equity
StockholdersEquity
20262
CY2006 imuc Common Stock Issued For Cash During Private Placements Net Of Redemptions
CommonStockIssuedForCashDuringPrivatePlacementsNetOfRedemptions
549400
CY2006 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
0
CY2006 imuc Share Cancelled In Connection With Sale Of Affiliate
ShareCancelledInConnectionWithSaleOfAffiliate
65000
CY2006 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
4103645
CY2006 us-gaap Net Income Loss
NetIncomeLoss
-5152713
CY2006Q4 us-gaap Stockholders Equity
StockholdersEquity
189662
CY2007 imuc Common Stock Issued For Cash During Private Placements Net Of Redemptions
CommonStockIssuedForCashDuringPrivatePlacementsNetOfRedemptions
4892486
CY2007 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2007 imuc Reclassification Of Warrant Derivative Liability
ReclassificationOfWarrantDerivativeLiability
2233600
CY2007 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1296714
CY2007 us-gaap Net Income Loss
NetIncomeLoss
-3614753
imuc Initial Capitalization Per Share
InitialCapitalizationPerShare
0.00002
imuc Common Stock Issued For Cash Per Share
CommonStockIssuedForCashPerShare
0.00078
CY2006 imuc Common Stock Issued For Services Per Share
CommonStockIssuedForServicesPerShare
0.50
CY2012 imuc Reclassification Of Warrant Derivative Liability
ReclassificationOfWarrantDerivativeLiability
1981743
CY2012 imuc Cashless Exercise Of Stock Options
CashlessExerciseOfStockOptions
0
CY2012 imuc Restricted Stock Value Shares Issued Vested
RestrictedStockValueSharesIssuedVested
0
CY2012 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
20500
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-14495139
imuc Exercise Of Warrants
ExerciseOfWarrants
4195297
imuc Cashless Exercise Of Warrants
CashlessExerciseOfWarrants
0
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
84131
imuc Cashless Exercise Of Stock Options
CashlessExerciseOfStockOptions
0
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
344074
CY2008 us-gaap Net Income Loss
NetIncomeLoss
-3059730
CY2008Q4 us-gaap Stockholders Equity
StockholdersEquity
2940336
CY2009 imuc Exercise Of Warrants
ExerciseOfWarrants
462748
CY2009 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
11814
CY2009 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
308302
CY2009 us-gaap Net Income Loss
NetIncomeLoss
-2626205
CY2009Q4 us-gaap Stockholders Equity
StockholdersEquity
1096995
CY2010 imuc Preferred Stock And Warrants Issued For Cash Net Of Offering Costs
PreferredStockAndWarrantsIssuedForCashNetOfOfferingCosts
0
CY2010 imuc Exercise Of Warrants In Exchange For Promissory Note
ExerciseOfWarrantsInExchangeForPromissoryNote
0
CY2010 imuc Redemption Of Preferred Stock For Repayment Of Promissory Note
RedemptionOfPreferredStockForRepaymentOfPromissoryNote
3307500
CY2010 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
26500
CY2010 imuc Cashless Exercise Of Stock Options
CashlessExerciseOfStockOptions
0
CY2010 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
745697
CY2010 imuc Interest On Promissory Note
InterestOnPromissoryNote
-1614
CY2010 us-gaap Net Income Loss
NetIncomeLoss
-6150142
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
2335830
CY2011 imuc Common Stock And Warrants Issued For Cash Net Of Offering Costs
CommonStockAndWarrantsIssuedForCashNetOfOfferingCosts
4983339
CY2011 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
388379
CY2011 imuc Cashless Exercise Of Stock Options
CashlessExerciseOfStockOptions
0
CY2011 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1190133
CY2011 imuc Interest On Promissory Note
InterestOnPromissoryNote
-352
CY2011 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
54634
CY2011 us-gaap Net Income Loss
NetIncomeLoss
-5719903
CY2011 imuc Common Stock Issued For Cash In Private Placements Per Share
CommonStockIssuedForCashInPrivatePlacementsPerShare
CY2010 imuc Common Stock Issued For Cash In Private Placements Per Share
CommonStockIssuedForCashInPrivatePlacementsPerShare
CY2011 imuc Common Stock And Warrants Issued For Cash Per Share
CommonStockAndWarrantsIssuedForCashPerShare
1.55
CY2010 imuc Common Stock And Warrants Issued For Cash Per Share
CommonStockAndWarrantsIssuedForCashPerShare
1.00
CY2010 imuc Preferred Stock And Warrants Issued For Cash Per Share
PreferredStockAndWarrantsIssuedForCashPerShare
10000
CY2012 imuc Exercise Of Warrants
ExerciseOfWarrants
3201920
CY2012 imuc Cashless Exercise Of Warrants
CashlessExerciseOfWarrants
0
CY2012 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
496007
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
21684
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
22888
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
96969
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-3817
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-3817
imuc Interest Accrued On Promissory Note
InterestAccruedOnPromissoryNote
0
imuc Interest Accrued On Promissory Note
InterestAccruedOnPromissoryNote
0
imuc Interest Accrued On Promissory Note
InterestAccruedOnPromissoryNote
0
us-gaap Share Based Compensation
ShareBasedCompensation
344074
us-gaap Share Based Compensation
ShareBasedCompensation
348724
us-gaap Share Based Compensation
ShareBasedCompensation
8997930
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
98703
imuc Common Stock Issued For Research And Development
CommonStockIssuedForResearchAndDevelopment
0
imuc Common Stock Issued For Research And Development
CommonStockIssuedForResearchAndDevelopment
0
imuc Common Stock Issued For Research And Development
CommonStockIssuedForResearchAndDevelopment
1335760
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-307594
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
526800
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
484813
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-403588
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-560266
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
328913
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
128546
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3238
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
494002
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4117822
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6889220
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-32661796
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
34441
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5668
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
190133
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
-25000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-34441
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5668
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-215133
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
84131
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
11000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
534844
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
3049638
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2199193
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
6714304
us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
0
us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
0
us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
53018
imuc Proceeds From Issuance Of Common Stock And Warrants From Underwritten Public Offering
ProceedsFromIssuanceOfCommonStockAndWarrantsFromUnderwrittenPublicOffering
404208
imuc Proceeds From Issuance Of Common Stock And Warrants From Underwritten Public Offering
ProceedsFromIssuanceOfCommonStockAndWarrantsFromUnderwrittenPublicOffering
9371370
imuc Proceeds From Issuance Of Common Stock And Warrants From Underwritten Public Offering
ProceedsFromIssuanceOfCommonStockAndWarrantsFromUnderwrittenPublicOffering
47397987
imuc Proceeds From Issuance Of Preferred Stock And Warrants Net Of Offering Costs
ProceedsFromIssuanceOfPreferredStockAndWarrantsNetOfOfferingCosts
0
imuc Proceeds From Issuance Of Preferred Stock And Warrants Net Of Offering Costs
ProceedsFromIssuanceOfPreferredStockAndWarrantsNetOfOfferingCosts
0
imuc Proceeds From Issuance Of Preferred Stock And Warrants Net Of Offering Costs
ProceedsFromIssuanceOfPreferredStockAndWarrantsNetOfOfferingCosts
3779158
us-gaap Payments For Purchase Of Other Assets
PaymentsForPurchaseOfOtherAssets
150000
us-gaap Payments For Purchase Of Other Assets
PaymentsForPurchaseOfOtherAssets
0
us-gaap Payments For Purchase Of Other Assets
PaymentsForPurchaseOfOtherAssets
150000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3387977
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
11581563
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
58329311
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-764286
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4686675
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
25452382
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6653168
CY2004Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11339843
us-gaap Interest Paid
InterestPaid
0
us-gaap Interest Paid
InterestPaid
0
us-gaap Interest Paid
InterestPaid
0
us-gaap Income Taxes Paid
IncomeTaxesPaid
0
us-gaap Income Taxes Paid
IncomeTaxesPaid
0
us-gaap Income Taxes Paid
IncomeTaxesPaid
0
imuc Exercise Of Warrants In Exchange For Promissory Note
ExerciseOfWarrantsInExchangeForPromissoryNote
0
imuc Exercise Of Warrants In Exchange For Promissory Note
ExerciseOfWarrantsInExchangeForPromissoryNote
0
imuc Exercise Of Warrants In Exchange For Promissory Note
ExerciseOfWarrantsInExchangeForPromissoryNote
3350000
imuc Redemption Of Preferred Stock For Repayment Of Promissory Note
RedemptionOfPreferredStockForRepaymentOfPromissoryNote
0
imuc Redemption Of Preferred Stock For Repayment Of Promissory Note
RedemptionOfPreferredStockForRepaymentOfPromissoryNote
0
imuc Redemption Of Preferred Stock For Repayment Of Promissory Note
RedemptionOfPreferredStockForRepaymentOfPromissoryNote
3350000
imuc Warrant Liability Converted To Additional Paid In Capital Upon Exercise
WarrantLiabilityConvertedToAdditionalPaidInCapitalUponExercise
1145659
imuc Warrant Liability Converted To Additional Paid In Capital Upon Exercise
WarrantLiabilityConvertedToAdditionalPaidInCapitalUponExercise
1622648
CY2012Q1 imuc Stock Issued During Period Shares Private Placement
StockIssuedDuringPeriodSharesPrivatePlacement
9489436
imuc Warrant Liability Converted To Additional Paid In Capital Upon Exercise
WarrantLiabilityConvertedToAdditionalPaidInCapitalUponExercise
3127404
us-gaap Escrow Deposit Disbursements Related To Property Acquisition
EscrowDepositDisbursementsRelatedToPropertyAcquisition
0
us-gaap Escrow Deposit Disbursements Related To Property Acquisition
EscrowDepositDisbursementsRelatedToPropertyAcquisition
35882
us-gaap Escrow Deposit Disbursements Related To Property Acquisition
EscrowDepositDisbursementsRelatedToPropertyAcquisition
35882
imuc Non Cash Deferred Offering Costs
NonCashDeferredOfferingCosts
0
imuc Non Cash Deferred Offering Costs
NonCashDeferredOfferingCosts
0
imuc Non Cash Deferred Offering Costs
NonCashDeferredOfferingCosts
182599
imuc Common Stock Issued For License Rights
CommonStockIssuedForLicenseRights
75000
imuc Common Stock Issued For License Rights
CommonStockIssuedForLicenseRights
0
imuc Common Stock Issued For License Rights
CommonStockIssuedForLicenseRights
75000
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin:9pt 0pt 0pt; text-indent:24.5pt; page-break-inside:avoid"><font style="font-family:&apos;Times New Roman&apos;; font-size:10pt; font-style:italic">Use of Estimates</font><font style="font-family:&apos;Times New Roman&apos;; font-size:10pt"> &#8211; The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make certain estimates and assumptions about the future outcome of current transactions which may affect the reporting and disclosure of these transactions. Accordingly, actual results could differ from those estimates used in the preparation of these financial statements. </font></p> </div>
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0074
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0084
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y6M15D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y2M1D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.905
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.6632
imuc Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeitures Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeituresRate
0
imuc Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeitures Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeituresRate
0
CY2013Q2 imuc Working Capital
WorkingCapital
25031191
CY2012Q4 imuc Working Capital
WorkingCapital
25832869
imuc Maturity Period Of Highly Liquid Instruments To Be Considered As Cash Equivalents Maximum
MaturityPeriodOfHighlyLiquidInstrumentsToBeConsideredAsCashEquivalentsMaximum
P90D
CY2012Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
23646922
CY2013Q2 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
22907190
us-gaap Property Plant And Equipment Estimated Useful Lives
PropertyPlantAndEquipmentEstimatedUsefulLives
generally three to five years
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2013Q2 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
10612215
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
21992841
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
20013824
CY2013Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
175443
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
151573
CY2013Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
90214
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
75284
CY2013Q2 us-gaap Depreciation
Depreciation
10842
CY2012Q2 us-gaap Depreciation
Depreciation
11444
us-gaap Depreciation
Depreciation
21684
us-gaap Depreciation
Depreciation
22888
us-gaap Depreciation
Depreciation
96969
CY2006Q4 imuc Stock Issued During Period Shares Issued For Upfront Licensing Fee
StockIssuedDuringPeriodSharesIssuedForUpfrontLicensingFee
694000
CY2006Q4 imuc Payment For Upfront Licensing Fee
PaymentForUpfrontLicensingFee
62000
CY2008Q4 imuc Funding From Equity For Milestone Minimum
FundingFromEquityForMilestoneMinimum
5000000
CY2009Q4 imuc Payment To Related Party For Clinical Trial
PaymentToRelatedPartyForClinicalTrial
166660
CY2008Q2 imuc Stock Issued During Period Shares Issued For Additional Licensing Fee
StockIssuedDuringPeriodSharesIssuedForAdditionalLicensingFee
100000
CY2011Q3 imuc Amount Of Funding From Equity Minimum After Amendment
AmountOfFundingFromEquityMinimumAfterAmendment
5000000
CY2010Q4 imuc Amount Of Funding From Equity Minimum After Amendment
AmountOfFundingFromEquityMinimumAfterAmendment
2500000
us-gaap Related Party Transaction Other Revenues From Transactions With Related Party
RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
330000
CY2013Q2 us-gaap Rental Properties
RentalProperties
4410
CY2016Q3 us-gaap Rental Properties
RentalProperties
8063
CY2013Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
17800
CY2012Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
12700
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
31000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
26000
imuc Percentage Of Annual Increase Of Monthly Base Rent
PercentageOfAnnualIncreaseOfMonthlyBaseRent
0.03
imuc Extended Term Of Agreement
ExtendedTermOfAgreement
2014-03-31
imuc Period Within Effective Date Of License Agreement
PeriodWithinEffectiveDateOfLicenseAgreement
P30D
imuc Nonrefundable And Noncreditable License And Maintenance Fee
NonrefundableAndNoncreditableLicenseAndMaintenanceFee
P12M
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10581194
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
267287
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
200401
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
5000
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10643080
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
9064475
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.16
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.61
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.04
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.95
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.28
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
1.07
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y9M22D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P3Y2M5D
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
8097234
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
8072450
CY2011Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
2157408
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
0
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
368524
imuc Warrants Exercised
WarrantsExercised
-1145660
imuc Warrants Exercised
WarrantsExercised
-1622649
imuc Warrant Liability Gain Loss Included In Earnings
WarrantLiabilityGainLossIncludedInEarnings
604171
imuc Warrant Liability Gain Loss Included In Earnings
WarrantLiabilityGainLossIncludedInEarnings
7795724
imuc Warrants Liability Transfers Net
WarrantsLiabilityTransfersNet
0
imuc Warrants Liability Transfers Net
WarrantsLiabilityTransfersNet
CY2012Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
8699007
CY2010Q2 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
2716308
CY2010Q2 imuc Stock Issued During Period Shares Private Placement
StockIssuedDuringPeriodSharesPrivatePlacement
2490910
CY2011Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
7460129
CY2011Q1 imuc Stock Issued During Period Shares Private Placement
StockIssuedDuringPeriodSharesPrivatePlacement
5219768
CY2011Q1 imuc Common Stock Shares Issuable Private Placement Warrants
CommonStockSharesIssuablePrivatePlacementWarrants
2609898
CY2012Q1 imuc Adjusted Exercise Price Of Warrants
AdjustedExercisePriceOfWarrants
1.87
CY2012Q1 imuc Common Stock Of Public Offering
CommonStockOfPublicOffering
2823670
CY2012Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
9271370
CY2013Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1724906
imuc Employee Service Share Based Compensation Nonvested Awards Compensation Cost Not Yet Recognized Period For Recognition Maximum
EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedPeriodForRecognitionMaximum
21 months
CY2013Q2 imuc Commission Rate
CommissionRate
0.03
CY2013Q2 imuc Listing Of Shares Of Common Stock In Connection With Sales Agreement
ListingOfSharesOfCommonStockInConnectionWithSalesAgreement
10593220
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
37000
CY2013Q2 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2012Q2 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2012Q4 imuc Common Stock Of Public Offering
CommonStockOfPublicOffering
2823670
CY2012Q4 imuc Adjusted Exercise Price Of Warrants
AdjustedExercisePriceOfWarrants
1.87
CY2013Q2 imuc Common Stock Shares Purchased Private Placement Warrant
CommonStockSharesPurchasedPrivatePlacementWarrant
2823670
imuc Common Stock Warrants Exercise Price Private Placement
CommonStockWarrantsExercisePricePrivatePlacement
1.94
CY2012 imuc Common Stock Warrants Exercise Price Private Placement
CommonStockWarrantsExercisePricePrivatePlacement
1.92
imuc Common Stock Warrants Exercise Price Private Placement
CommonStockWarrantsExercisePricePrivatePlacement
3.75
CY2012Q4 imuc Common Stock Shares Purchased Private Placement Warrant
CommonStockSharesPurchasedPrivatePlacementWarrant
2823670
CY2012 imuc Charge To Financing Expense
ChargeToFinancingExpense
397294
CY2012Q1 imuc Common Stock Warrants Exercise Price Private Placement
CommonStockWarrantsExercisePricePrivatePlacement
1.41
CY2012Q1 imuc Common Stock Shares Issuable Private Placement Warrants
CommonStockSharesIssuablePrivatePlacementWarrants
4744718
CY2012Q1 imuc Public Offering Expenses
PublicOfferingExpenses
1100000
CY2012Q4 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
19359553
CY2012Q4 imuc Public Offering Expenses
PublicOfferingExpenses
1600000
CY2012Q4 imuc Stock Issued During Period Shares Private Placement
StockIssuedDuringPeriodSharesPrivatePlacement
10000000
CY2012Q4 imuc Common Stock Shares Issuable Private Placement Warrants
CommonStockSharesIssuablePrivatePlacementWarrants
4500000
CY2012Q4 imuc Common Stock Warrants Exercise Price Investor Relations Agreement
CommonStockWarrantsExercisePriceInvestorRelationsAgreement
2.65
imuc Percentage Of Fair Market Value Of Common Stock
PercentageOfFairMarketValueOfCommonStock
not be less than 100%
imuc Percentage Of Common Stock Voting Rights Held
PercentageOfCommonStockVotingRightsHeld
more than 10%
imuc Minimum Percentage Of Fair Market Value Of Common Stock
MinimumPercentageOfFairMarketValueOfCommonStock
less than 110%
imuc Maximum Exercisable Period Of Options
MaximumExercisablePeriodOfOptions
P10Y
imuc Maximum Exercisable Period Of Options If Percentage Of Common Stock Voting Rights Held Is More Than Ten Percent
MaximumExercisablePeriodOfOptionsIfPercentageOfCommonStockVotingRightsHeldIsMoreThanTenPercent
P5Y
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
6000000
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
8000000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
3609656
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2010016
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
-0.34
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
-0.34
us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.06
us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.06
imuc Change In Fair Value Of Warrant Liability For Income Taxes
ChangeInFairValueOfWarrantLiabilityForIncomeTaxes
0.05
imuc Change In Fair Value Of Warrant Liability For Income Taxes
ChangeInFairValueOfWarrantLiabilityForIncomeTaxes
0.23
us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.35
us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.17
us-gaap Effective Income Tax Rate Reconciliation Tax Settlements
EffectiveIncomeTaxRateReconciliationTaxSettlements
0.00
us-gaap Effective Income Tax Rate Reconciliation Tax Settlements
EffectiveIncomeTaxRateReconciliationTaxSettlements
0.00
CY2013Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
14492100
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
12821749
CY2013Q2 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
1868932
CY2012Q4 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
1796954
CY2013Q2 us-gaap Valuation Allowance Amount
ValuationAllowanceAmount
16361032
CY2012Q4 us-gaap Valuation Allowance Amount
ValuationAllowanceAmount
14618703
CY2013Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
imuc Net Operating Losses Expire Date
NetOperatingLossesExpireDate
expire in 2022 and 2016

Files In Submission

Name View Source Status
0001564590-13-000239-index-headers.html Edgar Link pending
0001564590-13-000239-index.html Edgar Link pending
0001564590-13-000239.txt Edgar Link pending
0001564590-13-000239-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
imuc-10q_20130630.htm Edgar Link pending
imuc-20130630.xml Edgar Link completed
imuc-20130630.xsd Edgar Link pending
imuc-20130630_cal.xml Edgar Link unprocessable
imuc-20130630_def.xml Edgar Link unprocessable
imuc-20130630_lab.xml Edgar Link unprocessable
imuc-20130630_pre.xml Edgar Link unprocessable
imuc-ex10_20130629112.htm Edgar Link pending
imuc-ex10_20130629181.htm Edgar Link pending
imuc-ex31_20130629113.htm Edgar Link pending
imuc-ex31_20130629114.htm Edgar Link pending
imuc-ex32_20130629115.htm Edgar Link pending
imuc-ex32_20130629116.htm Edgar Link pending
j02000001.jpg Edgar Link pending
j02000002.jpg Edgar Link pending
j02000003.jpg Edgar Link pending
j02000004.jpg Edgar Link pending
j02000005.jpg Edgar Link pending
j02000006.jpg Edgar Link pending
j02000007.jpg Edgar Link pending
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R26.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R27.xml Edgar Link unprocessable
R28.htm Edgar Link pending
R28.xml Edgar Link unprocessable
R29.htm Edgar Link pending
R29.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R30.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R31.xml Edgar Link unprocessable
R32.htm Edgar Link pending
R32.xml Edgar Link unprocessable
R33.htm Edgar Link pending
R33.xml Edgar Link unprocessable
R34.htm Edgar Link pending
R34.xml Edgar Link unprocessable
R35.htm Edgar Link pending
R35.xml Edgar Link unprocessable
R36.htm Edgar Link pending
R36.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending